Are Health Care Stocks Back?

A New Half Begins With the first half of 2025 now in the books, investors are taking stock of the...

At the end of 2023, market prognosticators forecasted that 2024 would be a year of broadening, a...

The GLP-1 and weight loss drug landscape is teeming with innovation as companies test drugs with...

Originally developed for diabetes treatment, the discovery of GLP-1 therapeutics as a weight loss...

A recent report from the Centers for Disease Control and Prevention (CDC) at the end of 2023...

Addressing the Obesity Epidemic The global obesity epidemic has reached alarming proportions. Since...